Measurement of serum PODXL concentration for detection of pancreatic cancer

BACKGROUND: The aim of this study was to investigate the use of podocalyxin (PODXL) and secretoglobin family 1D, member 2 (SCGB1D2) expressions in whole blood as diagnostic biomarkers to distinguish between patients with pancreatic cancer and control participants, in comparison with serum cancer ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniuchi, Keisuke, Tsuboi, Makiko, Sakaguchi, Masahiko, Saibara, Toshiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858829/
https://www.ncbi.nlm.nih.gov/pubmed/29588598
http://dx.doi.org/10.2147/OTT.S155367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858829/
https://www.ncbi.nlm.nih.gov/pubmed/29588598
http://dx.doi.org/10.2147/OTT.S155367

Ejemplares similares